Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, according to new research that looked at health data from over 130 million individuals.
J&J jumps on ADC train, signs $1.7bn licensing deal with LegoChem
Share this article J&J also acquired the remaining global rights for Nanobiotix’s radioenhancer oncology drug, NBTXR3, from LianBio. Image Credit: Michael Vi / Shutterstock. Johnson